These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37608964)

  • 41. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Sykes KJ; Morrow E; Smith JB; Holcomb AJ; TenNapel M; Lominska CE; Bur AM; Kakarala K
    Head Neck; 2020 Oct; 42(10):2948-2957. PubMed ID: 33174308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative radiotherapy delay in head and neck cancer patients undergoing major resection and free flap reconstruction.
    Lee CW; Dupré S; Marlborough F; Iqbal MS; Kelly C; Bashir MA; Ahmed OA; Ragbir M; Saleh DB
    J Plast Reconstr Aesthet Surg; 2022 Jul; 75(7):2084-2089. PubMed ID: 35351393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
    Wan XC; Egloff AM; Johnson J
    Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma.
    Wushou A; Hou J; Zhao YJ; Miao XC
    J Craniomaxillofac Surg; 2015 May; 43(4):553-8. PubMed ID: 25797388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database.
    Cannon RB; Kull AJ; Carpenter PS; Francis S; Buchmann LO; Monroe MM; Lloyd S; Hitchcock YJ; Cannon D; Weis JR; Houlton JJ; Hunt JP
    Head Neck; 2019 Jun; 41(6):1873-1879. PubMed ID: 30652375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy.
    Rühle A; Marschner S; Haderlein M; Fabian A; Weymann M; Behrens M; Senger C; Dickstein DR; Kraft J; von der Grün J; Chen E; Aquino-Michaels T; Domschikowski J; Bickel A; Altay-Langguth A; Kalinauskaite G; Lewitzki V; Ferentinos K; Zamboglou C; Schnellhardt S; Haehl E; Spohn SKB; Gkika E; Zöller D; Guckenberger M; Budach V; Belka C; Bakst R; Mayer A; Schmidberger H; Grosu AL; Balermpas P; Stromberger C; Nicolay NH
    JAMA Netw Open; 2023 Feb; 6(2):e230090. PubMed ID: 36808242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Pang J; Faraji F; Risa E; Mell LK; Houlton JJ; Califano JA
    Head Neck; 2021 Sep; 43(9):2672-2684. PubMed ID: 33998088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].
    Marques O; Brenet E; Gaultier V; Marchand-Crety C
    Cancer Radiother; 2023 Feb; 27(1):17-22. PubMed ID: 35853823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.
    Corso CD; Rutter CE; Wilson LD; Kim AW; Decker RH; Husain ZA
    J Thorac Oncol; 2015 Jan; 10(1):148-55. PubMed ID: 25325781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
    Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
    Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An equity-based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Noyes EA; Burks CA; Larson AR; Deschler DG
    Laryngoscope Investig Otolaryngol; 2021 Dec; 6(6):1358-1366. PubMed ID: 34938875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiotherapy interruption due to holidays adversely affects the survival of patients with nasopharyngeal carcinoma: a joint analysis based on large-scale retrospective data and clinical trials.
    Xu C; Yang KB; Feng RJ; Chen L; Du XJ; Mao YP; Li WF; Liu Q; Sun Y; Ma J
    Radiat Oncol; 2022 Feb; 17(1):36. PubMed ID: 35183221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.